NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE100635 Query DataSets for GSE100635
Status Public on Dec 26, 2019
Title Histamine H3 receptor agonist regulates the expression of inflammation-related genes in kidney and heart of ANS-treated mice
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary We found the impaired renal function accompanied with severe cardiac dysfunction in mice co-treated with angiotensin II, nephrectomy and salt (ANS), and identified the increased level of plasma histamine in ANS-treated mice. Interestingly, pro-inflammatory genes were increased in kidneys of ANS-treated animals, which were down-regulated by histamine H3 receptor (H3R) agonist. Purpose: To evaluate the molecular mechanisms underlying the effect of the H3R agonist on the ANS-induced renal and cardiac inflammation, we performed a comprehensive analysis of ANS-mediated gene expression changes with/without H3R agonist in kidneys and hearts using RNA sequencing (RNA-Seq). Results: To investigate differentially expressed genes (false discovery rate (FDR) p<0.05, fold change >2) among three groups, we performed pairwise comparisons of RNA-Seq data using the CLC Genomics Workbench software. In comparison with the control of kidney group, 1,283 (1,010 up- and 273 down-regulated) unique genes were significantly changed in the ANS-treated group. Meanwhile, the data set of ANS-treated kidneys with H3R agonist revealed significant changes in 234 (65 up- and 169 down-regulated) genes as compared with the control groups. In case of hearts, the ANS-treated group revealed that 85 (66 up- and 19 down-regulated) unique genes were significantly changed compared to the control groups. Furthermore, in comparison with the ANS-treated with H3R agonist group, one up-regulated gene was significantly changed in the ANS-treated group.
 
Overall design Renal and cardiac mRNA profiles of control (Sham), angiotensin II, nephrectomy and salt (ANS)-treated and ANS-treated with H3R agonist mice were generated by RNA sequencing using the NextSeq 500 (Illumina).
Web link https://www.pnas.org/content/early/2020/01/27/1909124117.long
 
Contributor(s) Kim J, Noguchi K, Fukamizu A
Citation(s) 31992639
Submission date Jun 28, 2017
Last update date Jan 30, 2020
Contact name Jun-Dal Kim
Organization name University of Toyama
Department Department of Complex Biosystem Research (CBR), Institute of National Medicine (INM)
Lab Complex Biosystem Research Lab.
Street address 2630 Sugitani
City Toyama
State/province Toyama
ZIP/Postal code 930-0194
Country Japan
 
Platforms (1)
GPL19057 Illumina NextSeq 500 (Mus musculus)
Samples (25)
GSM2689761 Sham #1
GSM2689762 Sham #2
GSM2689763 Sham #3
Relations
BioProject PRJNA392329
SRA SRP110715

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE100635_Heart_Shamvs.H_ANSvs.H_ANS_H3a.xlsx 45.2 Mb (ftp)(http) XLSX
GSE100635_Kidney_Shamvs.ANSvs.ANS+H3R.xlsx 89.7 Mb (ftp)(http) XLSX
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap